documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
25 rows where docket_id = "FDA-1995-S-0036" and posted_year = 2012 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1995-S-0036-0135 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110280, British Columbia, Canada Public Disclosure Material Report 63 - Report | Other | Report | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2014-11-28T19:44:04Z | 0 | 0 | 090000648118f830 | ||
| FDA-1995-S-0036-0136 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | University of Texas Health Science Center at Houston re IND 14929, University of Alabama Public Disclosure Material Report 64 - Report | Other | Report | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2014-11-28T19:44:18Z | 0 | 0 | 090000648118f832 | ||
| FDA-1995-S-0036-0137 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Rampart Neurological Emergencies Treatment Trials Neuro Emergencies Research, Community Consultion and Public Disclosure IND 102254 Report 65 - Report | Other | Report | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2014-11-28T19:44:31Z | 0 | 0 | 090000648119e1fd | ||
| FDA-1995-S-0036-0134 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110280, Alabama Public Disclosure Material Report 62 - Report | Other | Report | 2012-12-17T05:00:00Z | 2012 | 12 | 2012-12-17T05:00:00Z | 2014-11-28T19:43:50Z | 0 | 0 | 090000648117af5b | ||
| FDA-1995-S-0036-0130 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | University of Texas Health Science Center at Houston, Sites University of Arizona, Toronto Sunnybrook Health Science, and Oregon Health & Science University, Public Disclosure Material, IND 14929 Report 56 - Report | Other | Report | 2012-11-30T05:00:00Z | 2012 | 11 | 2012-11-30T05:00:00Z | 2014-11-28T19:42:46Z | 0 | 0 | 0900006481136a1b | ||
| FDA-1995-S-0036-0133 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110280, Ottawa Public Disclosure Material Report 61 - Report | Other | Report | 2012-11-30T05:00:00Z | 2012 | 11 | 2012-11-30T05:00:00Z | 2014-11-28T19:43:35Z | 0 | 0 | 090000648116f518 | ||
| FDA-1995-S-0036-0131 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | University of Texas Health Science Center at Houston, Site University of Washington, Public Disclosure Material Report 59 - Report | Other | Report | 2012-11-30T05:00:00Z | 2012 | 11 | 2012-11-30T05:00:00Z | 2014-11-28T19:43:01Z | 0 | 0 | 0900006481167d02 | ||
| FDA-1995-S-0036-0132 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Penn Medicine Hospital of the University of Pennsylvania, IND 110314 Report 60 - Report | Other | Report | 2012-11-30T05:00:00Z | 2012 | 11 | 2012-11-30T05:00:00Z | 2014-11-28T19:43:15Z | 0 | 0 | 090000648116f517 | ||
| FDA-1995-S-0036-0128 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) Pittsburgh Public Disclosure Materials Report 57 - Report | Other | Report | 2012-11-14T05:00:00Z | 2012 | 11 | 2012-11-14T05:00:00Z | 2014-11-28T19:42:19Z | 0 | 0 | 0900006481159612 | ||
| FDA-1995-S-0036-0129 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | University of Texas Health Science Center at Houston, Site University of Southern California Los Angeles, Public Disclosure Material Report 58 - Report | Other | Report | 2012-11-14T05:00:00Z | 2012 | 11 | 2012-11-14T05:00:00Z | 2014-11-28T19:42:32Z | 0 | 0 | 0900006481159613 | ||
| FDA-1995-S-0036-0127 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Eunice Kennedy Shriver National Institute of Child Health and Human Development Public Disclosure Materials re IND 79010 Lorazepam Report 55 - Report | Other | Report | 2012-11-01T04:00:00Z | 2012 | 11 | 2012-11-01T04:00:00Z | 2014-11-28T19:42:00Z | 0 | 0 | 0900006481131644 | ||
| FDA-1995-S-0036-0126 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) British Columbia Public Disclosure Materials re IND 110699 Report 54 - Report | Other | Report | 2012-09-20T04:00:00Z | 2012 | 9 | 2012-09-20T04:00:00Z | 2014-11-28T19:41:42Z | 0 | 0 | 0900006481113f5e | ||
| FDA-1995-S-0036-0125 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | University of Texas Health Science Center at Houston, University of Cincinnati Academic Health Center, University of California, San Fancisco General Hospital, and the University of Tennessee Health Science Center Public Disclosure Materials re IND 14929 Report 53 - Report | Other | Report | 2012-09-17T04:00:00Z | 2012 | 9 | 2012-09-17T04:00:00Z | 2014-11-28T19:41:27Z | 0 | 0 | 09000064810f87aa | ||
| FDA-1995-S-0036-0124 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110699, Alabama Public Disclosure Material Report 52 - Report | Other | Report | 2012-08-10T04:00:00Z | 2012 | 8 | 2012-08-10T04:00:00Z | 2014-11-28T19:41:15Z | 0 | 0 | 09000064810c9d2e | ||
| FDA-1995-S-0036-0123 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110699, Portland Public Disclosure Material Report 51 - Report | Other | Report | 2012-07-23T04:00:00Z | 2012 | 7 | 2012-07-23T04:00:00Z | 2014-11-28T19:41:00Z | 0 | 0 | 09000064810a0006 | ||
| FDA-1995-S-0036-0122 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110699, Milwaukee Public Disclosure Material Report 50 - Report | Other | Report | 2012-07-12T04:00:00Z | 2012 | 7 | 2012-07-12T04:00:00Z | 2014-11-28T19:40:47Z | 0 | 0 | 090000648108a994 | ||
| FDA-1995-S-0036-0121 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Attachment - Community Consultantion for ResQPRO Clinical Trial (Advanced Circulatory Systems, Inc., to the Division of Dockets Management re: IDE G080169, ResQpro Clinical Trial, Community Consultation Plan - Report) re FDA-1995-S-0036-0112 | Supporting & Related Material | Report | 2012-07-12T04:00:00Z | 2012 | 7 | 2014-11-28T19:38:30Z | 0 | 0 | 0900006480e373e6 | |||
| FDA-1995-S-0036-0120 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110280, Toronto Public Disclosure Material Report 49 - Report | Other | Report | 2012-06-11T04:00:00Z | 2012 | 6 | 2012-06-11T04:00:00Z | 2014-11-28T19:40:34Z | 0 | 0 | 09000064810420f5 | ||
| FDA-1995-S-0036-0119 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110280, San Diego Public Disclosure Material Report 48 - Report | Other | Report | 2012-06-01T04:00:00Z | 2012 | 6 | 2012-06-01T04:00:00Z | 2014-11-28T19:40:21Z | 0 | 0 | 0900006481025646 | ||
| FDA-1995-S-0036-0118 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | ProTECT Emergency Neurosciences Department of Emergency Medicine (Emory University Scool of Medicine) re IND 104 188, Institutional Review Board Public Disclosure Material Report 47 - Report | Other | Report | 2012-04-26T04:00:00Z | 2012 | 4 | 2012-04-26T04:00:00Z | 2014-11-28T19:40:05Z | 0 | 0 | 0900006480ff7ad9 | ||
| FDA-1995-S-0036-0117 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110280, Final Community Consultation Plan Public Disclosure Material Report 46 - Report | Other | Report | 2012-04-24T04:00:00Z | 2012 | 4 | 2012-04-24T04:00:00Z | 2014-11-28T19:39:51Z | 0 | 0 | 0900006480ff17ed | ||
| FDA-1995-S-0036-0116 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Penn Medicine Hospital of the University of Pennsylvania Community Consultation and Public Disclosure AVERT Shock Trial IRB Protocol 811293 Report 45 - Report | Other | Report | 2012-04-04T04:00:00Z | 2012 | 4 | 2012-04-04T04:00:00Z | 2014-11-28T19:39:37Z | 0 | 0 | 0900006480fe6925 | ||
| FDA-1995-S-0036-0113 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110699, Community Consultation Plan Public Disclosure Material Report 42 - Report | Other | Report | 2012-04-02T04:00:00Z | 2012 | 4 | 2012-04-02T04:00:00Z | 2014-11-28T19:38:58Z | 0 | 0 | 0900006480fdb2e5 | ||
| FDA-1995-S-0036-0115 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Neuren Pharmaceuticals, Ltd., re IND 111724, Exception FromxInformed Consent Requirements for Emergency Research Public Disclosure Information Report 44 - Report | Other | Report | 2012-04-02T04:00:00Z | 2012 | 4 | 2012-04-02T04:00:00Z | 2014-11-28T19:39:25Z | 0 | 0 | 0900006480fdb2e6 | ||
| FDA-1995-S-0036-0114 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110280, Community Consultation Plan Public Disclosure Material Report 43 - Report | Other | Report | 2012-04-02T04:00:00Z | 2012 | 4 | 2012-04-02T04:00:00Z | 2014-11-28T19:39:12Z | 0 | 0 | 0900006480fdb2e3 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);